The proposed Mouse Metabolic Physiology Center (MMPC) is an interdisciplinary program that will expand the already extensive capacity at Vanderbilt to uniquely characterize the phenotype or genetically altered murine models of diabetes and related disorders. Moreover, it will provide a vehicle for making these novel resources available to investigators nationally. The MMPC will be self-contained in that it will have the capacity to perform husbandry and experimentation of a mouse line, analysis of tissue or blood samples from those mice, and management of data generated as a result of Center procedures. The MMPC will consist of five cores. The Administrative Core will provide scientific, financial, and administrative leadership, interact with program officials at the NIH, and administer the Pilot and Feasibility (P&F) Program. The Administrative Core will also support the role of the Center's Data Management Resource in developing and managing the Center mouse phenotyping database in a way that allows controlled access to investigators and other national centers. The Animal Care and Welfare Core will perform daily mouse care, mouse breeding, other national centers. The Animal Care and Welfare Core will perform daily mouse care, mouse breeding, collection of blood and tissues, and genotyping. The Metabolic Pathophysiology, the Vascular Pathology, and the Analytical Resources Core Laboratories will perform the phenotyping procedures. Pathophysiology, and the Analytical Resources Core Laboratories will perform the phenotyping procedures. Pathophysiology, and the Analytical Resources Core Laboratories will perform the phenotyping procedures. Services provided by cores will involve unique experimental procedures and analytical techniques scaled to the mouse that are generally not feasible for individual investigators to establish in their own laboratories. Vanderbilt is a leading site for research in diabetes and metabolism that is unified by the nation's first and consequently oldest federally funded diabetes center. Establishment of the MMPC will allow the expertise in diabetes and related disorders at Vanderbilt to be merged with developed and evolving resources to study the mouse.
Brown, Judy J; Short, Sarah P; Stencel-Baerenwald, Jennifer et al. (2018) Reovirus-Induced Apoptosis in the Intestine Limits Establishment of Enteric Infection. J Virol 92: |
Schlegel, Cameron; Lapierre, Lynne A; Weis, Victoria G et al. (2018) Reversible deficits in apical transporter trafficking associated with deficiency in diacylglycerol acyltransferase. Traffic 19:879-892 |
McClatchey, Penn Mason; Mignemi, Nicholas A; Xu, Zhengang et al. (2018) Automated quantification of microvascular perfusion. Microcirculation :e12482 |
Williams, Ian M; McClatchey, P Mason; Bracy, Deanna P et al. (2018) Acute Nitric Oxide Synthase Inhibition Accelerates Transendothelial Insulin Efflux In Vivo. Diabetes 67:1962-1975 |
Moore, Mary Courtney; Smith, Marta S; Farmer, Ben et al. (2018) Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day. Diabetes 67:1237-1245 |
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255 |
Moore, Mary Courtney; Kelley, David E; Camacho, Raul C et al. (2018) Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts. Diabetes 67:1173-1181 |
Funkhouser-Jones, Lisa J; van Opstal, Edward J; Sharma, Ananya et al. (2018) The Maternal Effect Gene Wds Controls Wolbachia Titer in Nasonia. Curr Biol 28:1692-1702.e6 |
Wasserman, David H; Wang, Thomas J; Brown, Nancy J (2018) The Vasculature in Prediabetes. Circ Res 122:1135-1150 |
Huynh, Frank K; Hu, Xiaoke; Lin, Zhihong et al. (2018) Loss of sirtuin 4 leads to elevated glucose- and leucine-stimulated insulin levels and accelerated age-induced insulin resistance in multiple murine genetic backgrounds. J Inherit Metab Dis 41:59-72 |
Showing the most recent 10 out of 661 publications